Delivery Order SPE2DB22D2009-SPE2DB24FM2EP

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation, is for the provision of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,243.25, has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The $2,949.00 fixed-price contract has a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the company to...
This federal contract award, valued at $1,179.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, with a completion date of September 9, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6HFK, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,335.06 firm fixed-price delivery order is for the procurement of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,036.15 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pediatric vaccine product, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INFANRIX DTAP SYRINGE 0.5ML vaccines. This $1,204.90 contract has a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor for this order, which is a child contract under a potential $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA to supply...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The order is a firm-fixed-price contract with a ceiling value of $1,769.40 and an ultimate completion date of September 30, 2024. The award was made on September 27, 2024, and there is no set-aside designation. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of INFANRIX DTAP SYRINGE 0.5ML, a childhood vaccine, to support the Department of Defense's medical treatment programs and facilities worldwide. The order has a firm fixed price of $1,474.50 and a completion date of May 23, 2024. AmerisourceBergen, through its...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.35, is for the delivery of INFANRIX SYRINGE 10S, a medical product. The contract has a completion date of January 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DB20D1109|SPE2DB23FN94C, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560599191 units of INFANRIX DTAP SYRINGE 0.5ML, with a ceiling value of $11,578.40. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is April 17, 2023. This award is not designated with a set-aside, indicating open competition....
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM2EP
    Delivery Order

This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,769.40 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen holds a significant indefinite delivery contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order is part of that larger IDC vehicle. The contract does not have a set-aside designation.

Generated 12/24/24, 9:36 AM